These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

172 related articles for article (PubMed ID: 18178171)

  • 1. Antitumor effect of the angiogenesis inhibitor bevacizumab is dependent on susceptibility of tumors to hypoxia-induced apoptosis.
    Selvakumaran M; Yao KS; Feldman MD; O'Dwyer PJ
    Biochem Pharmacol; 2008 Feb; 75(3):627-38. PubMed ID: 18178171
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Anti-VEGF antibody therapy induces tumor hypoxia and stanniocalcin 2 expression and potentiates growth of human colon cancer xenografts.
    Miyazaki S; Kikuchi H; Iino I; Uehara T; Setoguchi T; Fujita T; Hiramatsu Y; Ohta M; Kamiya K; Kitagawa K; Kitagawa M; Baba S; Konno H
    Int J Cancer; 2014 Jul; 135(2):295-307. PubMed ID: 24375080
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Inhibition of JNK Sensitizes Hypoxic Colon Cancer Cells to DNA-Damaging Agents.
    Vasilevskaya IA; Selvakumaran M; Hierro LC; Goldstein SR; Winkler JD; O'Dwyer PJ
    Clin Cancer Res; 2015 Sep; 21(18):4143-52. PubMed ID: 26023085
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Differential involvement of vascular endothelial growth factor in the survival of hypoxic colon cancer cells.
    Calvani M; Trisciuoglio D; Bergamaschi C; Shoemaker RH; Melillo G
    Cancer Res; 2008 Jan; 68(1):285-91. PubMed ID: 18172321
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Autophagy inhibition sensitizes colon cancer cells to antiangiogenic and cytotoxic therapy.
    Selvakumaran M; Amaravadi RK; Vasilevskaya IA; O'Dwyer PJ
    Clin Cancer Res; 2013 Jun; 19(11):2995-3007. PubMed ID: 23461901
    [TBL] [Abstract][Full Text] [Related]  

  • 6. In vitro hypoxia-conditioned colon cancer cell lines derived from HCT116 and HT29 exhibit altered apoptosis susceptibility and a more angiogenic profile in vivo.
    Yao K; Gietema JA; Shida S; Selvakumaran M; Fonrose X; Haas NB; Testa J; O'Dwyer PJ
    Br J Cancer; 2005 Dec; 93(12):1356-63. PubMed ID: 16333244
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Macrophage migration inhibitory factor is a determinant of hypoxia-induced apoptosis in colon cancer cell lines.
    Yao K; Shida S; Selvakumaran M; Zimmerman R; Simon E; Schick J; Haas NB; Balke M; Ross H; Johnson SW; O'Dwyer PJ
    Clin Cancer Res; 2005 Oct; 11(20):7264-72. PubMed ID: 16243796
    [TBL] [Abstract][Full Text] [Related]  

  • 8. (99)mTc-(CO)(3) His-annexin A5 micro-SPECT demonstrates increased cell death by irinotecan during the vascular normalization window caused by bevacizumab.
    Vangestel C; Van de Wiele C; Van Damme N; Staelens S; Pauwels P; Reutelingsperger CP; Peeters M
    J Nucl Med; 2011 Nov; 52(11):1786-94. PubMed ID: 22045708
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Hypoxia-mediated induction of the polyamine system provides opportunities for tumor growth inhibition by combined targeting of vascular endothelial growth factor and ornithine decarboxylase.
    Svensson KJ; Welch JE; Kucharzewska P; Bengtson P; Bjurberg M; Påhlman S; Ten Dam GB; Persson L; Belting M
    Cancer Res; 2008 Nov; 68(22):9291-301. PubMed ID: 19010902
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Disruption of signaling through SEK1 and MKK7 yields differential responses in hypoxic colon cancer cells treated with oxaliplatin.
    Vasilevskaya IA; Selvakumaran M; O'Dwyer PJ
    Mol Pharmacol; 2008 Jul; 74(1):246-54. PubMed ID: 18436711
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Intrinsic bevacizumab resistance is associated with prolonged activation of autocrine VEGF signaling and hypoxia tolerance in colorectal cancer cells and can be overcome by nintedanib, a small molecule angiokinase inhibitor.
    Mésange P; Poindessous V; Sabbah M; Escargueil AE; de Gramont A; Larsen AK
    Oncotarget; 2014 Jul; 5(13):4709-21. PubMed ID: 25015210
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Quercetin enhances hypoxia-mediated apoptosis via direct inhibition of AMPK activity in HCT116 colon cancer.
    Kim HS; Wannatung T; Lee S; Yang WK; Chung SH; Lim JS; Choe W; Kang I; Kim SS; Ha J
    Apoptosis; 2012 Sep; 17(9):938-49. PubMed ID: 22684842
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Anti-Vascular endothelial growth factor treatment augments tumor radiation response under normoxic or hypoxic conditions.
    Lee CG; Heijn M; di Tomaso E; Griffon-Etienne G; Ancukiewicz M; Koike C; Park KR; Ferrara N; Jain RK; Suit HD; Boucher Y
    Cancer Res; 2000 Oct; 60(19):5565-70. PubMed ID: 11034104
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Magnolol suppresses hypoxia-induced angiogenesis via inhibition of HIF-1α/VEGF signaling pathway in human bladder cancer cells.
    Chen MC; Lee CF; Huang WH; Chou TC
    Biochem Pharmacol; 2013 May; 85(9):1278-87. PubMed ID: 23416116
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Vascular endothelial growth factor is an in vivo survival factor for tumor endothelium in a murine model of colorectal carcinoma liver metastases.
    Bruns CJ; Liu W; Davis DW; Shaheen RM; McConkey DJ; Wilson MR; Bucana CD; Hicklin DJ; Ellis LM
    Cancer; 2000 Aug; 89(3):488-99. PubMed ID: 10931447
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Combined therapy using bevacizumab and turmeric ethanolic extract (with absorbable curcumin) exhibited beneficial efficacy in colon cancer mice.
    Yue GG; Kwok HF; Lee JK; Jiang L; Wong EC; Gao S; Wong HL; Li L; Chan KM; Leung PC; Fung KP; Zuo Z; Lau CB
    Pharmacol Res; 2016 Sep; 111():43-57. PubMed ID: 27241019
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Hypoxia-inducible factor-1 target genes as indicators of tumor vessel response to vascular endothelial growth factor inhibition.
    Dang DT; Chun SY; Burkitt K; Abe M; Chen S; Havre P; Mabjeesh NJ; Heath EI; Vogelzang NJ; Cruz-Correa M; Blayney DW; Ensminger WD; St Croix B; Dang NH; Dang LH
    Cancer Res; 2008 Mar; 68(6):1872-80. PubMed ID: 18339868
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Hypoxia-inducible factor-1alpha promotes nonhypoxia-mediated proliferation in colon cancer cells and xenografts.
    Dang DT; Chen F; Gardner LB; Cummins JM; Rago C; Bunz F; Kantsevoy SV; Dang LH
    Cancer Res; 2006 Feb; 66(3):1684-936. PubMed ID: 16452228
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Bevacizumab-induced transient remodeling of the vasculature in neuroblastoma xenografts results in improved delivery and efficacy of systemically administered chemotherapy.
    Dickson PV; Hamner JB; Sims TL; Fraga CH; Ng CY; Rajasekeran S; Hagedorn NL; McCarville MB; Stewart CF; Davidoff AM
    Clin Cancer Res; 2007 Jul; 13(13):3942-50. PubMed ID: 17606728
    [TBL] [Abstract][Full Text] [Related]  

  • 20. The BH3-mimetic obatoclax reduces HIF-1α levels and HIF-1 transcriptional activity and sensitizes hypoxic colon adenocarcinoma cells to 5-fluorouracil.
    Gariboldi MB; Taiana E; Bonzi MC; Craparotta I; Giovannardi S; Mancini M; Monti E
    Cancer Lett; 2015 Aug; 364(2):156-64. PubMed ID: 25979228
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 9.